ASX ANNOUNCEMENT 12 October 2026 Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889 Not for release to US wire services or distribution in the United States Non-Compliance with Listing Rule 10.11 Sydney, Australia – 12...
Non-Compliance with Listing Rule 10.11
Filed with ASX · · 4 pages · English
Release
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
- RAD Completes Meeting with US FDA for Development of RAD101
- Notification of cessation of securities - RAD
- Change of Director's Interest Notice (RC)
- Appendix 4G and Corporate Governance Statement
Later from Radiopharm Theranostics
- Change of Director's Interest Notices x 4
- Notification regarding unquoted securities - RAD
- Radiopharm receives $8M advance on FY26 R&D tax incentive
- Notice of Annual General Meeting/Proxy Form
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Radiopharm Theranostics into a list and get an email when it puts out news.
Follow Radiopharm Theranostics